| Income Statement |
| Total Revenue | 117.24M |
|
| Revenues (USD) | 117.24M |
| Cost of Revenue | 31.87M |
| Gross Profit | 85.37M |
| Operating Expenses | 72.64M |
| Research and Development Expense | 13.76M |
| Selling, General and Administrative Expense | 58.88M |
| Operating Income | 12.73M |
| Income Tax Expense | 1.29M |
| Net Income | 15.25M |
| Net Income Common Stock | 15.25M |
| Net Income Common Stock (USD) | 15.25M |
| Consolidated Income | 15.25M |
| Earnings per Basic Share | 0.07 |
| Earnings per Basic Share (USD) | 0.07 |
| Earnings per Diluted Share | 0.07 |
| Earning Before Interest & Taxes (EBIT) | 16.54M |
| Earning Before Interest & Taxes (USD) | 16.54M |
| Weighted Average Shares | 213.27M |
| Weighted Average Shares Diluted | 226.11M |
| Balance Sheet |
| Cash and Equivalents | 444.14M |
| Cash and Equivalents (USD) | 444.14M |
| Trade and Non-Trade Receivables | 100.41M |
| Current Assets | 562.25M |
| Property, Plant & Equipment Net | 28.26M |
| Total Assets | 734.19M |
| Total Debt | 13.27M |
| Current Liabilities | 260.26M |
| Debt Non-Current | 13.27M |
| Total Liabilities | 295.38M |
| Accumulated Retained Earnings (Deficit) | -531.32M |
| Accumulated Other Comprehensive Income | 6.13M |
| Shareholders Equity | 438.81M |
| Shareholders Equity (USD) | 438.81M |
| Assets Non-Current | 171.94M |
| Total Debt (USD) | 13.27M |
| Deferred Revenue | 203.59M |
| Goodwill and Intangible Assets | 48.69M |
| Liabilities Non-Current | 35.12M |
| Trade and Non-Trade Payables | 4.05M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.92M |
| Net Cash Flow from Financing | -58.87M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.92M |
| Capital Expenditure | -1.71M |
| Issuance (Purchase) of Equity Shares | -58.87M |
| Net Cash Flow from Investing | -1.60M |
| Net Cash Flow - Investment Acquisitions and Disposals | 105.00K |
| Net Cash Flow from Operations | 24.26M |
| Effect of Exchange Rate Changes on Cash | -712.00K |
| Share Based Compensation | 7.27M |